Efficacy and Safety of Omega-3 Fatty Acids for the Prevention of Atrial Fibrillation: A Meta-analysis

Canadian Journal of Cardiology

Volumn 29, Issue 2, 2013, Pages 196-203

  He, Zhiyu ^a   Yang, Lin ^a   Tian, Jinhui ^a   Yang, Kehu ^a   Wu, Julong ^a   Yao, Yali ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FISH OIL; OMEGA 3 FATTY ACID;

COCHRANE LIBRARY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EMBASE; HEART ATRIUM FIBRILLATION; HUMAN; MEDLINE; META ANALYSIS; OPEN HEART SURGERY; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; REVIEW; SECONDARY PREVENTION; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

ATRIAL FIBRILLATION; FATTY ACIDS, OMEGA-3; HUMANS; PRIMARY PREVENTION; RECURRENCE; SECONDARY PREVENTION;

EID: 84872677568     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2012.03.019     Document Type: Review

References (43)

1. Go A.S., Hylek E.M., Phillips K.A., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (atria) study. JAMA 2001, 285:2370-2375.
2. Feinberg W.M., Blackshear J.L., Laupacis A., et al. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 1995, 155:469-473.
3. Fuster V., Rydén L.E., Cannom D.S., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European Society of Cardiology committee for practice guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol 2006, 48:e149-e246.
4. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials [erratum in 1994;154:2254]. Arch Intern Med 1994, 154:1449-1457.
5. Stewart S., Hart C.L., Hole D.J., McMurray J.J. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 2002, 113:359-364.
6. Singh S.N., Patrick J. Antiarrhythmic drugs. Curr Treat Options Cardiovasc Med 2004, 6:357-364.
7. Podrid P.J. Proarrhythmia, a serious complication of antiarrhythmic drugs. Curr Cardiol Rep 1999, 1:289-296.
8. Calo L., Martino A., Sciarra L., et al. Upstream effect for atrial fibrillation: Still a dilemma?. Pacing Clin Electrophysiol 2011, 34:111-128.
9. Boos C.J., Anderson R.A., Lip G.Y. Is atrial fibrillation an inflammatory disorder?. Eur Heart J 2006, 27:136-149.
10. Korantzopoulos P., Kolettis T.M., Goudevenos J.A. The anti-inflammatory and antioxidant effects of long-chain n-3 fatty acids or oil-rich fish may favorably affect atrial remodeling in atrial fibrillation. Med Hypotheses 2005, 64:1245-1246.
11. Reiffel J.A., McDonald A. Antiarrhythmic effects of omega-3 fatty acids. Am J Cardiol 2006, 98:50i-60i.
12. Liu T., Li G. Anti-inflammatory effects of long-chain omega 3 fatty acids: potential benefits for atrial fibrillation. Med Hypotheses 2005, 65:200-201.
13. Laurent G., Moe G., Hu X., et al. Long chain n-3 polyunsaturated fatty acids reduce atrial vulnerability in a novel canine pacing model. Cardiovasc Res 2008, 77:89-97.
14. Jahangiri A., Leifert W.R., Patten G.S., McMurchie E.J. Termination of asynchronous contractile activity in rat atrial myocytes by n-3 polyunsaturated fatty acids. Mol Cell Biochem 2000, 206:33-41.
15. Mozaffarian D., Psaty B.M., Rimm E.B., et al. Fish intake and risk of incident atrial fibrillation. Circulation 2004, 110:368-373.
16. Brouwer I.A., Heeringa J., Geleijnse J.M., et al. Intake of very long-chain n-3 fatty acids from fish and incidence of atrial fibrillation. The rotterdam study. Am Heart J 2006, 151:857-862.
17. Frost L., Vestergaard P. N-3 fatty acids consumed from fish and risk of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Clin Nutr 2005, 81:50-54.
18. Berry J.D., Prineas R.J., van Horn L., et al. Dietary fish intake and incident atrial fibrillation (from the women's health initiative). Am J Cardiol 2010, 105:844-848.
19. Jadad A.R., Moore R.A., Carroll D., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996, 17:1-12.
20. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
21. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011] The Cochrane Collaboration, Accessed May 28, 2011. http://www.cochrane-handbook.org.
22. Sorice M., Tritto F.P., Sordelli C., et al. N-3 polyunsaturated fatty acids reduces post-operative atrial fibrillation incidence in patients undergoing "on-pump" coronary artery bypass graft surgery. Monaldi Arch Chest Dis 2011, 76:93-98.
23. Farquharson A.L., Metcalf R.G., Sanders P., et al. Effect of dietary fish oil on atrial fibrillation after cardiac surgery. Am J Cardiol 2011, 108:851-856.
24. Heidt M.C., Vician M., Stracke S.K., et al. Beneficial effects of intravenously administered n-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a prospective randomized study. Thorac Cardiovasc Surg 2009, 57:276-280.
25. Saravanan P., Bridgewater B., West A.L., et al. Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. Circ Arrhythm Electrophysiol 2010, 3:46-53.
26. Heidarsdottir R., Arnar D.O., Skuladottir G.V., et al. Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery?. Europace 2010, 12:356-363.
27. Calo L., Bianconi L., Colivicchi F., et al. N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol 2005, 45:1723-1728.
28. Kumar S., Sutherland F., Morton J.B., et al. Long-term omega-3 polyunsaturated fatty acid supplementation reduces the recurrence of persistent atrial fibrillation after electrical cardioversion. Heart Rhythm 2012, 9:483-491.
29. Nodari S., Triggiani M., Campia U., et al. N-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study. Circulation 2011, 124:1100-1106.
30. Ozaydin M., Erdogan D., Tayyar S., et al. N-3 polyunsaturated fatty acids administration does not reduce the recurrence rates of atrial fibrillation and inflammation after electrical cardioversion: a prospective randomized study. Anadolu Kardiyol Derg 2011, 11:305-309.
31. Kowey P.R., Reiffel J.A., Ellenbogen K.A., et al. Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial. JAMA 2010, 304:2363-2372.
32. Bianconi L., Cal L., Mennuni M., et al. N-3 polyunsaturated fatty acids for the prevention of arrhythmia recurrence after electrical cardioversion of chronic persistent atrial fibrillation: a randomized, double-blind, multicentre study. Europace 2011, 13:174-181.
33. Gillis A.M., Verma A., Talajic M., Nattel S., Dorian P. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management. Can J Cardiol 2011, 27:47-59.
34. Gaudino M., Andreotti F., Zamparelli R., et al. The -174g/c interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication?. Circulation 2003, 108(suppl 1):II195-II199.
35. Virtanen J.K., Mursu J., Voutilainen S., Tuomainen T.P. Serum long-chain n-3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men. Circulation 2009, 120:2315-2321.
36. Liu T., Korantzopoulos P., Shehata M., et al. Prevention of atrial fibrillation with omega-3 fatty acids: a meta-analysis of randomised clinical trials. Heart 2011, 97:1034-1040.
37. Benedetto U., Angeloni E., Melina G., et al. N-3 polyunsaturated fatty acids for the prevention of postoperative atrial fibrillation: a meta-analysis of randomized controlled trials. J Cardiovasc Med (Hagerstown) 2013, 14:104-109.
38. da Cunha D.N., Hamlin R.L., Billman G.E., Carnes C.A. N-3 (omega-3) polyunsaturated fatty acids prevent acute atrial electrophysiological remodeling. Br J Pharmacol 2007, 150:281-285.
39. Sarrazin J.F., Comeau G., Daleau P., et al. Reduced incidence of vagally induced atrial fibrillation and expression levels of connexins by n-3 polyunsaturated fatty acids in dogs. J Am Coll Cardiol 2007, 50:1505-1512.
40. Metcalf R.G., James M.J., Gibson R.A., et al. Effects of fish-oil supplementation on myocardial fatty acids in humans. Am J Clin Nutr 2007, 85:1222-1228.
41. Savelieva I., Camm A.J. Polyunsaturated fatty acids for prevention of atrial fibrillation: a 'fishy' story. Europace 2011, 13:149-152.
42. Parikka H., Toivonen L., Heikkila L., et al. Comparison of sotalol and metoprolol in the prevention of atrial fibrillation after coronary artery bypass surgery. J Cardiovasc Pharmacol 1998, 31:67-73.
43. Howard P.A., Barnes B.J. Potential use of statins to prevent atrial fibrillation after coronary artery bypass surgery. Ann Pharmacother 2008, 42:253-258.